References
- Plosker G L, Faulds D. Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension. Drugs 1996; 52: 232–253
- Wilson J, Commerford P J, Millar R S, Opie L H. Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction. Cardiovasc Drugs Ther 1992; 6: 41–46
- Mitchell J, Frishman W, Heiman M. Nisoldipine: A new dihydropyridine calcium-channel blocker. J Clin Pharmacol 1993; 3: 46–52
- Lip G Y, Fermer R E. Poisoning with antihypertensive drugs: Calcium antagonists. J Hum Hypertens 1995; 9: 155–161
- Koch A R, Vogelaers D P, Decruyenaere J M, Callens B, Verstraete A, Buylaert W A. Fatal intoxication with amlodipine. J Toxicol Clin Toxicol 1995; 33: 253–256
- Heinig R, Muschalek V, Ahr G. Determination of the enantiomers of nisoldipine in human plasma using high-performance liquid chromatography on a chiral stationary phase and gas chromatography with mass-selective detection. J Chromatogr Biomed Appl 1994; 655: 286–292
- Zimmer D, Muschalek V. Enantioselective assay for the determination of nisoldipine in dog, rat and mouse plasma by chiral microbore high-performance liquid chromatography combined with gas chromatography-mass spectrometry. J Chromatogr 1994; 666: 241–248
- van Harten J, Lodewijks M T, Guyt-Scholten J W, van Brummelen P, Breimer D D. Gas chromatographic determination of nisoldipine and one of its metabolites in plasma. J Chromatogr 1987; 423: 327–333
- Friedel H A, Sorkin E M. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs 1988; 36: 682–731
- Strubelt O, Diederich K W. Studies of antidote therapy for nisoldipine intoxication in experimental animals. Arzneimittelforschung 1990; 40: 747–751
- Pearigen P D, Benowitz N L. Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine. Drug Saf 1991; 6: 408–430